The future directions of artificial intelligence in the biological benefit-dominated diagnosis and treatment of pan-creatic cancer

VernacularTitle:人工智能技术在当前生物学获益为主的胰腺癌诊疗模式中的发展方向
Author: Zhong QI ¹ ; Ying XING ; Shi CHENG
Author Information

1. 首都医科大学附属北京天坛医院普通外科,北京 100070
Keywords: Artificial intelligence; Biological benefit; Pancreatic cancer; Diagnosis; Treatment
From: Journal of Surgery Concepts & Practice 2024;29(1):5-9
CountryChina
Language:Chinese
Abstract: Pancreatic cancer is a high malignant tumor with insidious onset,early metastasis,and extremely poor prognosis.How to improve the early diagnosis and the prognosis of the patients is the current research focus.Although traditional surgical resection may improve the prognosis of some patients,the long-term effect is still poor.Biological benefit is the new mode of pancreatic cancer treatment,and it is crucial to do the whole process monitoring,precisely make the treatment plan and predict the effect under this mode.Artificial intelligence technology,with its powerful data processing and image recognition functions and high learning efficiency,can help to build relatively perfect prediction models with the cooperation of multidisciplinary experts,assist clinicians to make optimal plans,and make the pancreatic cancer patients benefit from precision medicine and individualized therapy.